CMR Surgical and J&J partner on surgical robotics

CMR Surgical and J&J partner on surgical robotics

Versius Surgical Robotics Systems [Image courtesy of CMR Surgical]

CMR Surgical announced today that Johnson & Johnson MedTech subsidiary Ethicon will work with CMR to sell Versius surgical robotic systems in select markets.

The collaboration involves commercial teams from the two companies working together. They will focus on selling to selected hospitals in Italy, France, Germany and Brazil.

“By entering into this collaboration agreement with Ethicon in select markets, CMR believes that this combination of expertise in minimal access surgery and digital innovation will deliver an enhanced customer proposition,” said Per Vigard Nerseth, Chief Operating Officer, CMR. New release. “CMR looks forward to advancing this agreement in strategically important regions as CMR continues to rapidly expand on a global scale.”

The news comes just weeks after the Cambridge, UK-based surgical robotics startup announced it He has installed more than 100 Versius robotic surgery systems all over the world. There are now Versius bots operating across Europe, Asia, Australia, Latin America and the Middle East.

To meet the growing demand, CMR Surgical is building a world class manufacturing center of approximately 75,000 sq ft in Cambridgeshire.

The collaboration could lead to the global expansion of CMR Surgical

The partnership with Ethicon is the latest exciting turn of events in the robot-assisted surgery space. Many companies large and small are seeking to compete with Intuitive, the dominant company in the field of soft tissue surgical robots. (Here are 16 robotic surgery companies you should know. And the Here are eight more, including CMR.)

Versius features free port placement. The feature enables procedures tailored to each patient’s needs. For example, surgeons can perform the surgery the way they used laparoscopically but with the benefits of robotic surgery, according to the company. In addition, Versius features a compact and lightweight modular design in which health service provider staff can move around “effortlessly”.

CMR Surgical says the Versius is the only modular, portable mini robot on the market. The design makes it suitable for all sizes of hospitals and surgical care centers. Surgeons have the flexibility to perform a fully automated procedure or a combination of laparoscopic robotic and manual procedures. As a result, surgeons can determine which is best.

The partnership with Ethicon is in line with CMR Surgical’s rapid global expansion strategy. At the same time, CMR Surgical said it will continue to work and collaborate independently. In addition, investments will continue to be heavy for training and services for clients.

Where is Johnson & Johnson Ethicon heading in surgical robots?

Joint statement with maDevice J&J spokesperson Ryan Carbain explained Ethicon’s goals in the partnership: “The targeted collaboration agreement will focus on select hospitals in select regions, and will enable the Ethicon and CMR teams to jointly offer hospitals the benefits of their complementary portfolios. This business collaboration underscores Ethicon’s commitment to providing healthcare partners with the best surgical solutions in-class that focuses on the unique needs of each patient.”

Meanwhile, there hasn’t been much news regarding J&J Ethicon’s plans for its own Ottava system — with soft-tissue robots in play.

Today, the company’s statement was shared with maDevice He said, “We remain excited and committed to the OTAVA program. We look forward to offering a competitive robotic solution for soft tissues.”

Fortis Consultants He has an active lawsuit in Delaware on behalf of the Auris shareholders behind the Ottava technology and the earlier Monarch robotic system that J&J cleared for certain indications. Despite the challenges, Monarch continues to progress, Winning a new 510(k) in May.

J&J acquired Auris in 2019 for $3.4 billion. J&J calls the suit “totally without merit.”

#CMR #Surgical #partner #surgical #robotics

Leave a Comment

Your email address will not be published. Required fields are marked *